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Abstract 
Myopia, diabetes and aging are the main causes of progressive vitreous collagen aggregation, 
resulting in vitreous opacities which can significantly disturb vision. As vitreous opacities, 
which induce the visual phenomenon of ‘floaters’, are accessible with nanomaterials and light, 
we propose a nanotechnology-based approach to locally ablate them with highly reduced light 
energy compared to the more traditional YAG laser therapy. Our strategy relies on the plasmon 
properties of gold nanoparticles that generate vapor nanobubbles upon pulsed-laser illumination 
whose mechanical force can ablate vitreous opacities. We designed gold nanoparticles coated 
with hyaluronic acid which have excellent diffusional mobility in human vitreous, an essential 
requirement to reach the vitreous opacities. In addition, we found that HA-coated gold 
nanoparticles can accumulate extensively on human vitreous opacities which were obtained by 
vitrectomy from patients with vision degrading myodesopsia. When subsequently applying 
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nanosecond laser pulses, the collagen aggregates were efficiently destroyed with ~1000 times 
less light energy as typically used in YAG laser therapy. This low energy ‘floater-specific 
destruction’, which is due to the accumulation of the small gold nanoparticles on the opacities, 
is attractive as it may be safer to the surrounding ocular tissues while at the same time being 
easier and faster to apply compared to YAG laser therapy where the opacities need to be ablated 
piece by piece by a tightly focused laser beam. Gold nanoparticle assisted photo-ablation may 
therefore provide a safer, faster and more reliable destruction of vitreous opacities in the 
treatment of ophthalmologic diseases. 
Keywords: vitreous floaters, ophthalmology, pulsed-laser, gold nanoparticles, collagen fibers, 
collagen aggregates 
 





Proteins are important in living organisms, as they are involved in structural functions and play 
a role in many physiological processes. In some situations, misfolded or unfolded proteins can 
accumulate and form toxic biological aggregates which are involved in many diseases, such as 
amyloid diseases (Alzheimer’s disease, Parkinson disease…).1 While huge challenges remain 
to reach and treat amyloid aggregates in the brain, pathological aggregates also arise in other 
locations of the body that are more easily accessible to physical stimuli and advanced materials. 
In this investigation we focus on protein aggregates which form in the vitreous body of the 
human eye (Figure 1A). Vitreous is a colorless transparent gel mostly composed of water, 
collagen and negatively charged hyaluronic acid (HA).2 The collagen strands (‘fibrils’) and HA 
chains form a biomolecular network that confers gelatinous solidity to the vitreous body. 
However, in myopia and with aging, the vitreous body is increasingly liquefied due to structural 
changes in the biopolymer network and depolymerization of HA, resulting in collagen 
aggregation2. This destabilization of the vitreous body and concurrent dehiscence of vitreo-
retinal adhesion often result in acute posterior vitreous detachment and the sudden appearance 
of ‘floaters’ which disturb vision due to light scattering by the dense collagen matrix. Many 
patients suffering from vitreous floaters often complain of a significantly negative impact on 
their quality of life.3,4 All too often, patients with vitreous floaters are left untreated. However, 
recent advances have made available two therapeutic options: (i) pars plana vitrectomy,  i.e. the 
surgical removal of the patient’s vitreous  and its  replacement by a saline solution,5–7 or (ii) a 
non-invasive treatment of the vitreous opacities with a neodymium yttrium garnet laser 
(Nd:YAG).8 
The principle behind YAG laser therapy is that locally applied laser pulses (typically 2-8 mJ 
per pulse; up to 1000 shots per floater) result in plasma production and ’optical breakdown’ that 
may disrupt vitreous opacities.9,10 In 2002, a retrospective study indicated however that only 
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38% of patients treated with YAG laser found a moderate improvement in their symptoms, 
showing that YAG laser therapy is far from optimal,11,12 as confirmed in more recent studies.  
Furthermore, it is known that YAG laser therapy is not completely safe. Indeed, cases of 
cataract,13 open-angle glaucoma 14 and posterior lens capsule rupture 15 have been reported. 
Clearly, while treatment of biological aggregates in the vitreous with YAG lasers is an attractive 
approach, significant room for improvement remains. For instance, it is generally considered 
that the shape, size and location of the aggregates in the vitreous can have a detrimental impact 
on the YAG laser treatment efficacy, thereby necessitating a trial and error approach based on 
the practitioner’s observation and judgement.16,17 Therefore, technological improvements are 
needed that allow to photoablate vitreous collagen aggregates, no matter their size, shape or 
location, while being safe and easier to perform.  
Considering this clear clinical need, we developed a nanotechnology-based approach for more 
efficient photo-ablation of micro- and macroscopic opacities in human vitreous. In particular 
we rely on the surface plasmon properties of gold nanoparticles (AuNPs) which tremendously 
enhance laser light absorption.18,19 Upon pulsed-laser illumination (typically nanosecond laser 
pulses), AuNPs are quickly heating up to several hundred degrees. Consequently, the water of 
the surrounding environment evaporates to form vapor nanobubbles (VNBs) emerging around 
the surface of the AuNP (Figure 1B).18,20 Such VNBs will first expand and then collapse thereby 
generating high-pressure shockwaves. As illustrated in Figure 1C, we hypothesized that VNBs 
would allow to mechanically destroy opacities in the vitreous if AuNPs can be targeted to those 
opacities upon intravitreal injection, a well-accepted administration route to deliver (biological) 
drugs in the eye. We first explored our hypothesis making use of ’artificial vitreous opacities’ 
i.e. collagen fiber bundles obtained through heating of type I collagen solutions. We 
investigated (i) the intrinsic capacity of nanobubbles to break collagen fibers dispersed in water 
and (ii) the capacity of AuNPs functionalized with hyaluronic acid to diffuse in bovine vitreous 
and bind to collagen fibers. Subsequently, we tested the concept of gold nanoparticle assisted 
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Figure 1. (A) Dark-field microscopy of vitreous in an 88 year-old patient shows age-related aggregation of vitreous 
collagen into visible fibers in the central vitreous body that induce vision-disturbing floaters. The dense collagen 
matrix of the outer vitreous body (arrow) also induces floaters after separation from the retina (posterior vitreous 
detachment). With permission from 21. (B) Schematic representation of the generation of vapor nanobubbles 
(VNBs) from gold nanoparticles (AuNPs) illuminated with a pulsed-laser. (C) Schematic representation of the 
concept ‘gold nanoparticle assisted photo-ablation’: upon intravitreal injection AuNPs bind to the opacities; 







Nanobubbles generated from cationic AuNPs (cat-AuNPs) can break collagen fibers 
First, we evaluated if laser induced nanobubbles have the capacity to break artificially made 
collagen fibers. Collagen fibers were prepared through heating of type I collagen solutions. As 
Figure 2A shows, the collagen solution turned turbid upon heating at 37 °C, indicating the 
formation of collagen fibers (insert ii). These fibers in water were subsequently labeled with 
Col-F, a fluorescent probe which stains collagen and elastin.22 The presence of collagen fibers 
could be confirmed by dark field and fluorescence microscopy, an example of which is given 
in Figure 2B. As the dark field microscopy images in Figure 2C show, cat-AuNPs of 70 nm 
spontaneously bound to the collagen fibers. Figure 2D shows a dark field microscopy image of 
a collagen fiber carrying cat-AuNPs respectively before, during and after applying a single laser 
pulse of 200 µJ (~1.1 J/cm²); immediately after the laser pulse VNBs (which scatter laser light) 
can be observed on the fiber as bright spots. 
As Figure 2E and F indicate, a single laser pulse of either 200 µJ or 600 µJ (corresponding to a 
laser fluence of 1.1 and 3.3 J/cm², respectively) was not sufficient to break the collagen fibers. 
However, an 800 µJ laser pulse (~ 4.5 J/cm²) did affect the size of the collagen fibers, while the 







Figure 2. (A) Turbidity change of a collagen solution indicating the formation of collagen fibers. Inserts correspond 
to respectively a solution of collagen (i) and a dispersion of collagen fibers (ii). (B) Representative dark field and 
fluorescence microscopy images of a Col-F stained collagen fiber (in water) carrying 70 nm cat-AuNPs. (C) 
Representative images of collagen fibers (in water) before and after treatment with cat-AuNPs. The presence of 
cat-AuNPs on the collagen fibers can be appreciated in the right insert. (D) Dark field microscopy images of a 
collagen fiber carrying cat-AuNPs (1010 particles/ml) respectively before, during and after applying a single laser 
pulse of 200 µJ (~1.1 J/cm²): during the laser pulse VNBs (which reflect the laser light) can be observed on the 
fiber as bright spots. (E) Representative images of collagen fibers (in water) before and after treatment with 
nanobubbles; either a single pulse of 200 µJ (~1.1 J/cm²) or 10 pulses of 800 µJ (~4.5 J/cm²) were applied. The 
yellow dotted squares/rectangles indicate the position of the fibers. The scale bar in E is 100 µm. (F, G) Relative 
size of the collagen fibers upon treating the fibers under various conditions: the intensity (E; one laser pulse) or 
the number of laser pulses (F; 800 µJ; ~4.5 µJ/cm²) were varied. In all experiments the laser beam was focused on 
the center of the fibers. Fiber length was determined from the microscopy images using ImageJ software. Data are 
shown as mean +/- SD. Statistical significance: student’s t-test, * indicates p<0.05, ** indicates p<0.01, ns 
indicates non-significant. 
 
Coating of AuNPs with negatively charged HA prevents their immobilization in vitreous  
Clearly, to allow binding of AuNPs to opacities in vitreous, the AuNPs should not become 
immobilized at the injection spot but remain sufficiently mobile to be able to reach the fibers 
which may be a distance away from the injection spot. Upon injection of cat-AuNPs in bovine 
vitreous, we noticed they got immobilized. Dark field images revealed binding of the cat-
AuNPs to the vitreous network (Figure 3A). These observations are in agreement with earlier 
data from us and others 23,24 which showed the immobilization of cationic polystyrene 
nanoparticles and cationic liposomes in vitreous. This is highly likely attributed to the anionic 




As we have demonstrated before that coating of nanoparticles with negatively charged 
hyaluronic acid (HA) can restore their mobility in vitreous, 23,25–27 we synthesized hyaluronic 
acid-coated AuNPs (HA-AuNPs). The zeta-potential (ZP) of cat-AuNPs (in water) was + 39 
mV while it turned to -18 mV for HA-AuNPs (Figure 3B), confirming the coating of the gold 
nanoparticles with HA. 
 
Figure 3. (A) Dark field microscopy images of 70 nm cat-AuNPs in bovine vitreous show their immobilization on 
the collagen strands of the vitreous. (B) Zeta potential measurements of Cat-AuNPs and HA-AuNPs in water. 
To confirm whether HA coating of the AuNPs indeed avoids their obstruction in vitreous we 
used scattering recovery after fragmentation (SRAF), as explained in detail in the experimental 
section. Figure 4 shows a representative SRAF experiment on HA-AuNPs dispersed in water. 
The dark field microscopy image in the outmost left panel shows the scattered light by the gold 
NPs in suspension. Applying a single laser pulse in the indicated circular region causes the 
AuNPs to become fragmented, which locally reduces the intensity of the scattered light. Due to 
diffusion, intact AuNPs from the surrounding area gradually move into this fragmented zone, 
resulting in a gradual recovery of the light scattering intensity (Figure 4; right panel). The 
diffusion coefficient of the HA-AuNPs in water (as calculated from the recovery curve) was 
estimated to be around 3.2 +/- 0.1 µm2/s, which is fairly close to the D-value as measured by 
nanoparticle tracking analysis (NTA), being 4.7 +/-0.8 µm2/s (data not shown). The fact that 
SRAF underestimates the diffusion coefficient is likely due to the simplified semi-quantitative 
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method that we used to calculate it from the scattering recovery curve. Nevertheless, it is 
sufficiently reliable for our purpose, which is to verify if HA-AuNPs have better mobility in 
vitreous as compared to cat-AuNPs (see below). 
 
Figure 4. SRAF measurements on HA-AuNPs in water. Dark field microscopy images of a suspension of HA-
AuNPs (70 nm) in water before, during (t = 0 s) and after (t > 0 s) fragmentation of the HA-AuNPs in the 
fragmentation zone (which is indicated by the dotted circle; 100 µm in diameter). To fragment the HA-AuNPs a 
single 7 nanosecond laser pulse (200 µJ; ~1.1 J/cm²) was applied. The light scattering recovery curve is shown in 
the right panel (see Movie S1); the relative light scattering in the Y-axes is the light scattering as measured at a 
certain time point (in the fragmentation zone) divided by the light scattering measured (in the fragmentation zone) 
before fragmentation. The red symbols are the experimental data; the black line is the fitted curve. For movies, see 
supplementary material. 
Figure 5 shows the outcome of SRAF measurements on respectively cat-AuNPs and HA-AuNPs 
injected in bovine vitreous. Clearly, the nearly complete absence of light scattering recovery in 
the fragmentation zone (Figure 5, top panel) confirms that cat-AuNPs are mostly stuck in 
vitreous. Instead, HA-AuNPs have much better mobility in bovine vitreous (Figure 5, lower 
panel), with a diffusion coefficient (1.9 +/- 0.4 µm²/s) somewhat lower than in water, as could 
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be expected due to the presence of the biopolymer network in the vitreous.
 
Figure 5. SRAF measurements on HA-AuNPs in bovine vitreous. (A) Dark field microscopy images of cat-AuNPs 
(70 nm) and HA-AuNPs (70 nm) injected in bovine vitreous before and after fragmentation. The scale bar is 100 
µm. To fragment the HA-AuNPs a single 7 nanosecond laser pulse (200 µJ; ~1.1 J/cm²) was applied. The dotted 
circle indicates the fragmentation zone (around 100 µm diameter). As the panel at the right shows, while there was 
is no light scattering recovery for the cat-AuNPs (see also Movie S2) recovery clearly occurred for HA-AuNPs 
(see also Movie S3). The relative light scattering in the Y-axes of the panels at the right is the light scattering as 
measured at a certain time point (in the fragmentation zone) divided by the light scattering measured (in the 
fragmentation zone) before fragmentation. The red symbols are the experimental data; the lines represent the fitted 
curves. For movies, see supplementary material. 
 
Nanobubbles generated from (70 nm) HA-AuNPs allow to break collagen fibers 
To evaluate whether AuNPs, when coated with HA, bind collagen fibers and keep their capacity 
to break fibers (as seen with cat-AuNPs, Figure 2), HA-AuNPs were mixed with artificial 
collagen fibers dispersed in water. Figure 6 (top panel) shows that collagen fibers remain 
unaffected when exposed to a single 800 µJ (~4.5 J/cm²) laser pulse only (i.e. without treating 
them with HA-AuNPs). With a single laser pulse of 200 µJ (~1.1 J/cm²), collagen fibers 
‘carrying’ HA-AuNPs (note the accumulation of the HA-AuNPs on the fibers) were again 
poorly affected. Instead, when the intensity of the (single) laser pulse was increased up to 800 
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µJ (4.5 J/cm²), collagen fibers carrying HA-AuNPs became clearly broken (bottom panel) in 






Figure 6. Dark field microscopy images of collagen fibers (dispersed in water) respectively before, during and 
after applying a single laser pulse of different intensities. In the top row HA-AuNPs were not added while in the 
middle and bottom rows HA-AuNPs (70 nm; 1010 NPs/ml) were attached to the collagen fibers; the scale bar is 
100 µm. The yellow dotted squares/rectangles indicate the position of the targeted fiber. Dotted circles indicate 
the position of the laser beam. During laser treatment (merged) vapor nanobubbles can be appreciated as bright 
spots (middle panel in the second and third row).  
Binding of ‘small’ AuNPs (10 nm) to collagen fibers  
Clearly, the approach to break collagen fibers by laser light induced VNBs conceptually works 
when using 70 nm AuNPs. However, as evident from the dark field microscopy images, such 
fairly large AuNPs quite strongly scatter light. Strong scattering of light by intravitreally 
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injected nanoparticles would be highly undesirable as it might lower the visual acuity of the 
patient. Instead, it is well-known that light scattering is much weaker for smaller gold 
nanoparticles from which, however, VNBs are not easily formed.28 Yet, it has been reported 
before that it is still possible to generate VNB when those small AuNPs locally agglomerate to 
form effectively larger particle clusters,42 as already shown to happen at the surface of cells.43 
Seeing that HA-AuNPs did bind to collagen fibers (which is a form of local agglomeration), we 
subsequently studied whether or not smaller HA-AuNPs (i.e. 10 nm instead of 70 nm) still allow 
to form VNB and destroy the collagen fibers. 
First, we studied the binding of 10 nm HA-AuNPs (ZP=-22.1 +/-1.62 mV) to collagen fibers. 
As shown in Figure 7 A and B, TEM images confirmed the binding of small HA-AuNPs to 
collagen fibers with a density of approximately 45 NPs/µm2 and 250 NPs/µm2 when incubated 
at 1010 and 1012 NPs/ml, respectively. Figure 7C shows experimentally measured UV-VIS 
extinction spectra of respectively collagen fibers alone, HA-AuNPs in water (1012 NPs/ml) and 
HA-AuNPs bound to collagen fibers (1012 NPs/ml). It can be appreciated that at a concentration 
of 1012 NPs/ml, once the AuNPs bind to collagen fibers, a red shift of the maximum of the 
localized surface plasmon resonance (LSPR) peak occurs from 521 nm to 534 nm, indicative 
of particle clustering (plasmon coupling).  
The insert of panel C in Figure 7 shows photographs of (i) a collagen fiber suspension, (ii) a 
suspension of small HA-AuNPs (1012 NPs/ml) and (iii) a suspension of collagen fibers in the 
presence of small HA-AuNPs. The red color of the collagen fibers in presence of AuNPs (insert 
iii) is related to the binding of the AuNPs on the fibers, in agreement with the TEM images 
(Figure 7A and B) and red-shift of the extinction spectrum.  
To further confirm that the observed red-shift is due to particle clustering, in Figure 7 E and F 
we simulated the extinction spectra of respectively 10 nm AuNPs dispersed in water (non-
clustered; Figure 7D) and of 10 nm AuNPs attached to collagen fibers (in water) at a density of 
respectively 45 NPs/µm2 (Figure 7E) and 250 NPs/µm2 (Figure 7F). The simulations were 
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performed as reported previously by Fraire et al..44 The simulated extinction spectrum of free 
10 nm AuNPs in water (Figure 7D) had a peak at 521 nm, matching very well to the 522 nm 
peak that we found experimentally. At a density of 45 NPs/µm2 a red-shift occurred to 528 nm 
(Figure 7E), which became 532 nm at a density of 250 NPs/µm2 (Figure 7F). This matches 
again very well with the experimentally observed extinction peak at 534 nm, providing further 
evidence that the HA-AuNPs cluster upon binding to the collagen fibers. 
 
Figure 7. (A, B) Representative TEM images of collagen fibers (in water) carrying a lower (A; 45 NPs/µm²;  1010 
NPs/ml) or higher (B; 250 NPs/µm²; 1012 NPs/ml) amount of HA-AuNPs. (C) Experimentally measured UV-vis 
spectra of 10 nm HA-AuNPs dispersed in water (black) and added to a dispersion of collagen fibers (red: 1012 
NPs/ml). The insert shows a suspension of collagen fibers in water (i), HA-AuNPs in water (ii) and added to a 
dispersion of collagen fibers (iii). (D) Simulated optical response of 10 nm AuNPs dispersed in water (i.e. non-
clustered) and of collagen fibers (in water) carrying the 10 nm AuNPs at a density of (E) 45 NPs/µm2 (as in A) 
and (F) 250 NPs/µm2 (as in B). Note that in (D) and (E) the extinction and absorption completely overlap. For 




Photo-ablation of collagen fibers with 10 nm HA-AuNPs  
Subsequently we evaluated whether or not (i) vapor nanobubbles could still be generated from 
the 10 nm HA-AuNPs upon clustering to collagen fibers and (ii) if such nanobubbles allow to 
break collagen fibers dispersed in water or bovine vitreous.  
First, we noticed (Figure 8 A and B) that with 10 nm HA-AuNPs in water it was far more 
difficult to observe the formation of vapor nanobubbles, when compared to the 70 nm gold NPs. 
This size dependency was indeed expected 41 since at the laser fluences used in our study 10 
nm sized HA-AuNPs are too small to generate VNBs. The few VNBs observed at a laser fluence 
of around 3 J/cm² (Figure 8B) are most likely generated by some aggregated HA-AuNPs. Figure 
8 C and D show that applying a single laser pulse (800 µJ; ~4.5 J/cm²) to HA-AuNPs dispersed 
in bovine vitreous (1012 particles/ml) indeed generates VNBs with 70 nm HA-AuNPs (Figure 
8C) while VNBs are virtually absent with the 10 nm HA-AuNPs (Figure 8D), thus confirming 





Figure 8. (A,B) The number of VNBs counted in the irradiated zone upon applying a single laser pulse to HA-
AuNPs of a size of 70 nm (A) or 10 nm (B) in water. Note that a lower concentration of HA-AuNPs (1010 
particles/ml) was used in Figure 8 A and B to be able to ‘count’ the number of VNBs. (C,D) Dark field images of 
bovine vitreous in which 70 nm (C) or 10 nm (D) HA-AuNPs are dispersed (1012 particles/ml), respectively before 
and during exposing a single laser pulse of 800 µJ (4.5 J/cm²). During the laser pulse VNBs (which reflect the 
laser light) can be observed as bright spots. (E) Representative dark field microscopy images of collagen fibers (in 
water and bovine vitreous (Movie S4)) carrying 10 nm HA-AuNPs respectively before and after applying one, or 
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several, 800 µJ laser pulses (4.5 J/cm²). The collagen concentration equaled 0.02 mg/ml while the concentration 
of the HA-AuNPs was 1012 particles/ml. For movies, see supplementary material. 
However, while a single 800 µJ laser pulse (~4.5 J/cm²) did not generate VNBs from 10 nm 
HA-AuNPs ‘freely’ present in vitreous (Figure 8D), such a pulse was sufficient to destroy 
artificial collagen fibers (Figure 8E and Movie S4). This was made possible due to the 
outspoken accumulation (Figure 7B) and clustering (Figure 7C) of the 10 nm HA-AuNPs on 
the collagen fibers.   
Photo-ablation of human vitreous opacities with 10 nm HA-AuNPs  
Subsequently we investigated whether opacities present in vitreous of patients could be 
mechanically destroyed by vapor nanobubbles generated from locally accumulated 10 nm HA-
AuNP. Because the composition, the size and shape of those opacities can vary from one patient 
to another, our strategy was tested on different patient samples (Figure 9). Interestingly, we 
found that, like on artificial collagen fibers (Figure 8E), human vitreous opacities of different 
size and shape could be destroyed using the same the concentration of 10 nm HA-AuNPs (1012 




Figure 9. Dark field microscopy images of three human vitreous opacities (as obtained from three patients who 
underwent vitrectomy) carrying 10 nm HA-AuNPs, respectively before and after applying one, or several, laser 
pulses (800 µJ; ~4.5 J/cm²) (Movie S5). The concentration of the 10 nm HA-AuNPs suspension was 1012 
particles/ml. The scale bar in (A) and (B) is 100 µm. The yellow dotted squares/rectangles indicate the position of 
the targeted fibers (A) or vitreous floaters (B). Dotted circles indicate the position of the laser beam. For movies, 
see supplementary material. 
Human Müller cells survive the photo-ablation process  
Clearly, a relevant question is to whether AuNPs, laser pulses and shock waves as generated 
from vapor nanobubbles may be harmful to the retina. To get some first insights on this, we 
performed toxicity studies on immortalized human Müller cells, the principal glial cell type in 
the retina with end feet inserted into the vitreo-retinal interface.32 As Figure 10A indicates, 
when the cells are exposed to a single laser pulse of 200 µJ (~1.1 J/cm²) and 800 µJ (~4.5/cm²), 
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viability remained >80%. Also, when treated with 10 nm HA-AuNPs for 24h at a concentration 
which allows to break vitreous opacities (1012 particles/ml), cell viability remained >80% as for 
untreated cells (Figure 10B).  
Subsequently we aimed to get an indication on the survival of Müller cells when nanobubbles 
are generated on collagen fibers representative of central vitreous opacities 16 and located  a 
distance away from the cells. As Figure 10C shows, no effect was found on human Müller cells 
when the layer of collagen fibers (at a distance of 10 mm from the cells) was treated either with 




Figure 10. (A) Cell viability (MTT assay) of immortalized human Müller cells 24h after exposing the cells to the 
pulsed-laser only: each well was scanned (single scan) through the laser beam. (B) Cell viability 24h after treating 
the cells with 10 nm HA-AuNPs only (without applying laser light). (C) Cell viability of human Müller cells 
located at a distance of 10 mm from collagen fibers; the cells were first exposed to 10 nm HA-AuNPs (1012 
particles/ml) for 24h; subsequently the layer of collagen fibers was scanned (single scan) through the laser beam. 
In the control experiments of A, B and C, cells were untreated. 
 
Currently, the efficacy of YAG laser therapy for the treatment of vitreous opacities is far from 
optimal, lacking in objective quantitative evidence of efficacy. We propose to ‘photo-ablate’ 
vitreous opacities with a strategy allying pulsed-lasers and gold nanoparticles which might be 
promising for a more efficient and safer alternative to current treatments.  
Clearly, the human vitreous is a complex, and not yet completely understood, biological matrix. 
Controlling the biophysical behavior of nanomaterials injected in such a complex matrix is 
highly challenging. After injection in bovine vitreous, we observed that cationic AuNPs are 
immobilized (Figure 5; Movie S2), in agreement with earlier observations with other types of 
cationic NPs.25,26 Clearly, avoiding this represents a major challenge for AuNP assisted photo-
ablation as immobilization of the gold nanoparticles at the injection site prevents them from 
reaching the vitreous opacities. Based on our previous work,33 where we demonstrated that NP 
mobility in vitreous can be restored by applying a HA coating to the NPs, we observed that 
coating of AuNPs with HA avoids their immobilization in vitreous (Figure 5; Movie S3). 
Asakura et al. described that the collagen strands (‘fibrils’) in the biopolymer network of the 
vitreous are likely connected to HA (mediated by glycosaminoglycans (GAGs) such as 
chondroitin sulfates).34 The negatively charged HA on the collagen strands keep the strands 
sufficiently apart. This minimizes light scattering, keeping the vitreous transparent. This 
hypothesis was further confirmed later by Scott 35 who describes a three-component complex 
(collagen-GAG-HA-GAG-collagen) forming the vitreous network with possible interactions 
occuring between HA and GAG.36 As schematically presented in Figure 11A, electrostatic 
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repulsions may therefore possibly occur between HA-AuNPs and HA connected to the collagen 
strands, explaining why HA-AuNPs remain mobile in vitreous. Instead, cat-AuNPs likely bind 
to the negatively charged HA molecules, causing immobilization to the collagen strands 
(Figures 3 and 5 and Movie S2). 
 
Figure 11. (A) Schematic representation of the fate of HA-coated AuNPs in the vitreous. (B) Schematic representation of the 
binding of HA-AuNPs to a vitreous opacity. 
Surprisingly, while the negatively charged HA-AuNPs do not seem to interact with the collagen 
strands of the biopolymer network in vitreous (Figure 5 and Movie S3; and as schematically 
shown in Figure 11A), we found that they do bind to type I collagen fibers (Figure 6) and human 
vitreous opacities (Figure 9), similar to what was observed for cat-AuNPs (Figure 2). A possible 
explanation is the presence of both anionic sites and cationic groups on the surface of the 
collagen fibers that comprise vitreous opacities, as suggested in earlier studies.37,38 Also, as 
vitreous opacities are often present in liquefied parts of the vitreous, one can assume that HA 
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is absent on the surface of the opacities or, at least, present in a lower concentration in their 
immediate surroundings, as previously suggested by Sebag and Balazs.39 This absence of HA 
(and thus absence of electrostatic interactions) might explain why HA-AuNPs keep their 
binding capacity to opacities, as schematically illustrated in Figure 11B. 
We investigated the potential of 10 nm AuNPs for the photo-ablation process as smaller 
particles diffuse more easily through vitreous (a requirement to reach the floaters)23 while they 
scatter less light which might provide more comfort to the patient. At laser fluences used in our 
study, when freely dispersed in water or vitreous 10 nm sized HA-AuNPs seemed too small to 
generate VNBs (Figure 8), this in opposite to the 70 nm sized HA-AuNPs; this size dependency 
was indeed expected and in agreement with previous reports.41,51,52 Importantly, however, we 
noticed that 10 nm HA-AuNPs bind and cluster on the surface of collagen fibers (Figure 7). 
This binding and clustering of the AuNPs on the fibers improves light absorption and lowers 
the laser energy required to generate nanobubbles. This is an interesting finding as it allows to 
use laser pulses which are strong enough to generate nanobubbles on the fibers while they are 
too weak to generate nanobubbles in the surroundings. This ‘fiber-specific nanobubble 
generation’ is attractive as it may minimize potential damage to the surrounding vitreous and 
tissues.  
Since human vitreous opacities might contain several types of collagen and since the 
morphology and structure of floaters is highly variable between patients as well, we evaluated 
the photo-ablation potential of 10 nm HA-AuNPs on vitreous opacities obtained during 
vitrectomy on patients with vision degrading myodesopsia. Figure 9 and Movie S5 show 
representative examples. We observed that all opacities in the various human vitreous samples 
we investigated could be broken using experimental settings similar to the ones which allow to 
break type I collagen fibers (Figure 8E). We also observed that the morphology of floaters 
varied from one patient to another. Indeed, while some floaters give the impression of 
membranes, others seemed smaller and denser. The structural heterogeneity of floaters also 
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implies that for some of them more laser pulses were needed for destruction, as observed in 
Figure 9 for floaters obtained from patient 3. 
In traditional YAG laser vitreolysis, floaters are destroyed by plasma formation 42 requiring 
laser pulses at very high energy densities up to 5000 J/cm². Since a single YAG laser pulse 
typically has an energy in the order of 10 mJ,10 it means that the laser beam needs to be tightly 
focused to less than 20 µm diameter onto the floaters to achieve local photo destruction. 
Considering that vitreous opacities can have much larger dimensions, up to 1000 shots may be 
needed to destroy a single opacity, amounting to a total light dose of 104 mJ. In our approach, 
however, we use AuNPs as sensitizing agent to enhance light absorption so that much lower 
energy densities and total light doses are needed to achieve the same effect. Indeed, in this study 
the laser beam was 150 µm (diameter) and pulses had an energy of 0.8 mJ. This means that the 
light energy density was as low as 4.5 J/cm², which is approximately 1000 times less than what 
is used for YAG laser therapy. In addition, since consequently the laser beam can be much 
larger, fewer laser pulses are needed to completely destroy the fibers. Indeed, we needed about 
10 pulses to destroy opacities, which corresponds to a total light dose of about 10 mJ, again 
approximately 1000 times less than YAG laser therapy. Taken together, gold nanoparticle 
assisted photo-ablation of vitreous opacities might be less damaging for the posterior segment 
of the eye as a significantly lower number of weaker laser pulses seem to be sufficient to break 
opacities. Another practical advantage of being able to use a larger laser beam is that the 
distance along the optical axis (i.e. the direction of light propagation) over which a suitable 
energy density is achieved for photo-ablation is much larger. Indeed, assuming a Gaussian beam 
profile for simplicity, the depth of focus scales with the square of the beam spot size. This 
means that for our laser beam of 150 µm diameter, the depth of focus is at least 56 times ((150 
µm /20 µm)²) more extended as compared to the < 20 µm beam for the YAG laser. Practically 
this means that 3D focusing onto the floater is not such a stringent requirement, making the 
whole procedure much easier to perform. 
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These advantages come, of course, at the expense of having to introduce sensitizing AuNPs 
into the vitreous, which raises questions about potential toxic effects. Even though the toxicity 
of several types of nanoparticles to the retina has been reported in literature,43 few reports study 
toxicological effects of AuNPs on the retina. It has been reported that 20 nm AuNPs 
intravenously injected in rabbits were able to cross the blood retinal barrier without affecting 
cell viability or inducing structural changes in the retina.44 In another study AuNPs were 
intravitreally injected in rabbits and histological observations were performed up to one month 
without showing clear signs of toxicity.45 Furthermore, it is also known that AuNPs have anti-
angiogenic and anti-inflammatory properties which can improve the treatment of 
ophthalmological diseases.46 This relative safety of using AuNPs was also confirmed in our 
preliminary toxicity study on Müller cells, which possess end feet at the vitreo-retinal interface. 
Indeed, when incubated with 1012 NP/ml, cell viability remained > 80% which is often regarded 
as the acceptable toxicity limit for in-vitro cell experiments. This was a worst-case experiment 
as in vivo the effective dose which reaches the cells will be limited due to dilution effects. 
Another concern may be if cells are affected by the laser light itself. Even though our approach 
uses light intensities and total doses that are much less than what is currently used in traditional 
YAG laser therapy, we double checked this explicitly on Müller cells in vitro. As expected, cell 
viability remained very good. Finally, we tested if the generation of VNBs from vitreous 
opacities located at the centre of the vitreous body may be harmful to nearby retinal cells. We 
noticed that, in case collagen fibers are located at a distance of 10 mm from the Müller cells 
(taken as a representative position of vitreous opacities from the retina), no toxicity was 
observed (Figure 10C).  
Regarding the further translation of gold nanoparticle assisted photo-ablation into clinical 
practice, also the half-life of the gold particles in the vitreous is of major importance. Indeed, 
the gold nanoparticles should stay for a sufficiently long time in the vitreous to allow the photo-
ablation of opacities. Measuring the half-life of gold nanoparticles in animal models could make 
sense. However, to which extent this information would be sufficiently predictive for the 
26 
 
clearance of gold nanoparticles in human eyes is not so clear. Following the mechanistic model 
described by Hutton-smith et al.,47 the half-life of intravitreally-injected drugs/nanoparticles 
can be (partially) estimated from their diffusion coefficient in vitreous. For gold nanoparticles 
of 10 nm, taking into account their diffusion coefficient in vitreous and the volume of vitreous 
in human eyes, we estimate the half-life in vitreous to be approximately one day. It suggests 
that the intravitreal injection of the gold nanoparticles and the laser treatment should be 




In this study, we have presented a nanomaterial-based approach which might be promising for 
the treatment of vitreous opacities that cause vision degrading myodesopsia. We conclude that 
vapor nanobubbles, which arise upon applying nanosecond laser pulses to gold nanoparticles, 
deliver sufficient mechanical energy to break human opacities as present in the vitreous of 
patients who underwent vitrectomy. We observed that gold particles coated with hyaluronic 
acid, being a major component of vitreous, do not get stuck in vitreous while they accumulate 
on the opacities. This clustering of gold nanoparticles lowers the intensity of the laser pulses 
needed to generate vapor nanobubbles on the opacity. Local ‘floater-specific nanobubble 
generation’ is attractive as it might preserve the surrounding vitreous and ocular tissues. Due to 
the clustering of the gold particles on the opacities, even small (10 nm) gold particles generate 
vapor nanobubbles on the opacities which can break them.  Such small nanoparticles are 
especially attractive as we showed that they easily diffuse in vitreous, a requirement to reach 
the opacities after intravitreal injection, while they scatter less light which might provide more 
comfort to the patient. Important as well, compared to current YAG laser therapy for floaters 
in which patients receive hundreds of mJoule-shots in the eye, a much smaller number of low 
intensity laser shots (µJoule) seem sufficient to break vitreous opacities causing floaters. In 
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conclusion, our experiments have shown promising results to treat vitreous disorders which 
may enlarge the therapeutic perspectives on the use of pulsed-lasers and nanotechnology in the 




The following materials were used as obtained: HAuCl4 (Aldrich); sodium citrate (Aldrich); 
sodium L-ascorbate (Sigma-Aldrich); hyaluronic acid 20 kDa (HA) (Aldrich); poly(diallyl-
dimethyl-ammonium chloride) (PDDAC) solution (20 wt. % in H2O; Aldrich), rat tail collagen 
type I acid solution (Sigma-Aldrich) and Col-F (Immunochemistry Technologies LLC). 
Synthesis of gold nanoparticles 
The synthesis of 70-80 nm AuNPs was performed using the Turkevich method.49 Therefore, to 
150 mL of a 0.2 mM chloroauric acid (HAuCl4) solution (in water), 0.5 mL of a 0.01 M citrate 
solution (in water; as reducing agent; corresponding to a 1:1 Au/citrate molar ratio) was added. 
To obtain ‘gold seeds’ this mixture was heated (to boiling temperature) and rapidly stirred for 
30 min. The gold seeds were overgrown by addition of 0.005 M gold ion (Au3+ in water) and, 
subsequently, added with an ascorbate solution (0.005 M in water; as a strong reducing agent) 
until the UV-vis extinction spectrum (as measured by a Nanodrop 2000c spectrophotometer) of 
70-80 nm AuNPs was observed i.e. extinction between 538-542 nm. 
The synthesis of 10 nm AuNPs was performed using ascorbate as reducing agent. A typical 
synthesis consists in mixing HAuCl4 (in water) and sodium ascorbate (in water) at equimolar 
ratios (concentration 0.2 mM, final volume 100 mL) under rapid stirring. We allowed the 
reaction to proceed until the UV-vis extinction spectrum of 10 nm AuNPs was observed. 
Measuring the size and concentration of the gold nanoparticles  
The AuNPs were characterized by UV-vis spectroscopy, dynamic light scattering (DLS), TEM 
and electrodynamic modeling using Mie theory. The concentration of the AuNPs in the 
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dispersions was estimated from the extinction of the dispersions as measured at the maximal 




) = 𝐸𝑥𝑡 (𝑏 × EXT)⁄  
Where ‘b’ is the optical path (1 cm) and ’EXT’ (cm
2) is the theoretical extinction cross section 
for spherical particles obtained by Mie theory calculations.51 
Surface coating of the gold nanoparticles 
The Au nanoparticles were coated with respectively negatively charged HA (HA-AuNPs) or 
positively charged PDDAC (cat-AuNPs). Typically, coating with HA was performed by adding 
3 mg HA (previously dissolved in 1 mL distilled deionized (ddi) water) to 50 mL of an AuNP 
dispersion in water (2-4 pM). Coating with PDDAC was performed by addition of 11.9 mg of 
PDDAC (previously dissolved in 1 mL ddi water) to 50 mL of a dispersion of HA-coated 
AuNPs (2-4 pM). After reaction overnight, thus obtained coated gold nanoparticles were 
washed by centrifugation (10 min at 13000g for 10 nm AuNPs and 5 min at 2000g for 70-80 
nm AuNPs) and resuspended in water. To confirm a successful coating of the gold 
nanoparticles, DLS and zeta potential measurements were performed (Zetasizer Nano, 
Malvern). 
Simulation of the optical properties of gold nanoparticles 
The optical responses (i.e. scattering, absorption and extinction) of AuNPs were computed 
using Mie theory, which constitutes an exact solution to the problem of absorption and 
scattering of light by an object composed by concentric spheres.52 In particular, we used the 
Generalized Multiparticle Mie Theory (GMM) formulation developed by Xu.53 This method is 
able to exactly solve the complex problem of interaction between an electromagnetic field and 
an aggregate of spheres, and was used to simulate the extinction, scattering and absorption cross 
sections. In all the calculations presented in this work the dielectric function tabulated by Palik 
for Au was employed.54 In the calculations performed in this work the NPs were excited by a 
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plane wave with an incidence pointing vector (propagation direction) normal to the surface. As 
the GMM code is restricted to applications in homogeneous media, we used an effective 
medium approximation 55 to account for the interface between the particle surface and the 
aqueous environment. We considered that particles were immersed in a dielectric environment 
with an effective refractive index (neff) of 1.35, which was calculated as the weighted average 
of 20% of the refractive index of collagen (nr 1.41) and 80 % of the refractive index of water 
(nr 1.33).
56 
Formation of collagen fibers as a model for vitreous opacities 
Collagen I from rat tail was dissolved in PBS (0.2 mg/ml); the pH of the collagen solution was 
increased to 7.4 with NaOH (0.1N). Subsequently, the collagen solution was incubated at 37°C 
for one hour. To follow the fibrillation process, turbidity experiments were performed by 
measuring the absorbance of the collagen suspension (λ400 nm) at 37°C (using a NanoDrop 
2000c spectrophotometer). Collagen fibers were stained with Col-F probe.22 Therefore, the 
collagen fiber dispersion was incubated for 4h at room temperature with Col-F (in DMSO) to 
reach a final Col-F concentration of 20 µM and subsequently centrifuged to remove the excess 
of the probe. 
Vitreous samples  
Bovine vitreous containing collagen type I fibers 
Bovine eyes were enucleated less than one hour after cows were slaughtered (slaughterhouse 
Zele, Belgium). Since vitreous has a very fragile structure, it was carefully removed from the 
globe. First, 200 to 400 µl was carefully cut and placed on a glass-bottomed culture dish. 
Subsequently 50 µl of the suspension of collagen type I fibers was injected in the vitreous 
sample using a 1 ml syringe equipped with a 21.5G needle and let to equilibrate at room 
temperature for 30 min. AuNPs were then randomly injected in the sample (no more than 40 µl 
per injection) using a 1 ml syringe equipped with a 30G needle (no more than 5 injection spots 
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per vitreous sample to avoid extensive liquefaction). The sample was let to equilibrate for 30 
min prior to applying (nanosecond) laser pulses (Opolette HE 355 LD laser, OPOTEK Inc.) 
Human vitreous containing opacities 
Samples of vitreous containing  opacities were collected at the VMR Institute for Vitreous 
Macula Retina (Huntington beach, CA, USA) from patients undergoing vitrectomy for the 
treatment of Vision Degrading Myodesopsia.7,57,58 The study protocol adhered to the 
Declaration of Helsinki. Prior to surgery, patients gave a written informed consent that has been 
reviewed and accepted by the ethical committee of Saint Joseph Health Center for clinical 
research (Irvine, CA, USA). After vitrectomy the (undiluted) samples were frozen and stored 
at -80°C until further use. After thawing the human vitreous samples, they were directly mixed 
with an equal volume of a dispersion of AuNPs (typically 1012 NPs/ml in water). The samples 
were then allowed to equilibrate for 30 min at room temperature prior to applying (nanosecond) 
laser pulses. 
Measuring the mobility of AuNPs in vitreous through SRAF  
SRAF (scattering recovery after fragmentation) measurements were performed to determine the 
mobility (diffusion) of the AuNPs in the bovine vitreous. Following our experience on 
fluorescence recovery after photobleaching (FRAP),59,60 we here propose SRAF and used it to 
determine the diffusion of light scattering AuNPs. FRAP is a well-known fluorescence 
microscopy-based technique that is commonly used in pharmaceutical and biological research 
to assess the diffusion of fluorescent molecules or nanoparticles in various media 61 and, as we 
showed more recently, to measure the size of fluorescent (nano)particles dispersed in complex 
biofluids like serum.62 As Figure 12 (top panel, first row) illustrates, FRAP is performed by 
applying a high intensity laser beam in a defined region of (typically) a few micrometers in size 
(’bleached’ region) which leads to the destruction of the fluorophores present in this area. In 
case the fluorescent molecules are mobile a recovery of fluorescence in the bleached region will 
subsequently occur over time. From this fluorescence recovery curve the diffusion coefficient 
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of the fluorescent molecules can be calculated.61 Inspired by the FRAP method we measured 
the mobility of the light scattering (non-fluorescent) gold nanoparticles using dark field 
microscopy. Therefore, as Figure 12 (top panel, second row) illustrates, first the intensity of the 
scattered light (originating from the gold NPs) in a micrometer sized zone in the sample was 
measured. Second, a single laser pulse was applied in that zone. As we know from the literature 
and our previous observations that this ‘fragments’ the gold NPs,63 and therefore decreases their 
size, light scattering in this ‘fragmentation zone’ decreases, resulting in a local dark spot in the 
images. From the light scattering recovery in the fragmentation zone, due to the diffusion of 
unaffected AuNPs from the surroundings in the fragmentation zone, the mobility (diffusion 
coefficient) of the gold nanoparticles could be quantified.  
For SRAF mobility experiments in water, 5 µL of AuNPs suspension (1012 particles/ml in 
water) was placed on a microscopy slide. For measuring the mobility of the AuNPs in the 
vitreous through SRAF, 40 µL of a highly concentrated suspension of AuNPs (typically 1012 
particles/ml in water) was injected in a bovine vitreous sample (200-400 µl) contained in a 
glass-bottomed dish and allowed to equilibrate for 30 min. Then samples were placed under the 
dark field microscope (10x objective) and illuminated with the nanosecond laser (Opolette HE 
355 LD, OPOTEK Inc; 561 nm; 200 µJ; 1.1 J/cm²; 1 pulse) to fragment the AuNPs; 
subsequently the increased intensity of scattered light in the fragmentation zone was recorded 
for about 10 min. Recovery curves were obtained from NIS software. As the nanosecond 
pulsed-laser beam was fairly circular and uniform, the diffusion coefficient (D; in µm²/s) was 
estimated  according to D = w²/4τ (equation 2) with w the radius (µm) of the fragmentation 
zone and 𝜏 the half-life of scattering recovery (s).64 The curves were fitted using a third order 
polynomial function. Note that in all SRAF experiments 70 nm AuNPs were used since they 




Figure 12. Scattering recovery after fragmentation (SRAF) and its analogy with fluorescence recovery after 
photobleaching (FRAP). 
 
Nanoparticle tracking analysis (NTA) 
To measure the diffusion of the AuNPs in water, NTA measurements were performed with a 
Nanosight instrument (Malvern). Therefore, AuNPs were diluted in water (1010 NPs/ml) and 
injected with a sterile syringe in the sample chamber. Measurements were made using the 




Photo-ablation of collagen fibers and human vitreous opacities  
Photo-ablation experiments were performed on the samples described in the previous sections 
(collagen fibers in bovine vitreous and human vitreous containing opacities). First, dark field 
microscopy imaging was performed to locate and align the nanosecond laser on the collagen 
fibers or human vitreous opacities in the sample. To generate vapor nanobubbles, 7ns laser 
pulses were used. The wavelength of the laser light was 561 nm which corresponds to the 
plasmon peak of 70-80 nm AuNPs. A beam expander (#GBE05-A, Thorlabs) combined with 
iris diaphragm (#D37SZ, Thorlabs) was used to adjust the diameter of the laser beam to 150 
µm. The laser pulse energy was monitored by an energy meter (J-25MB-HE&LE, Energy Max-
USB/RS sensors, Coherent) synchronized with the pulsed-laser. The length of the collagen 
fibers was determined from the microscopy images using ImageJ software. 
Transmission electron microscopy to study the binding of AuNPs to collagen fibers   
Transmission electron microscopy (TEM) images were obtained using a JEM-JEOL 1120 EXII 
under an accelerating voltage of 80 kV. One drop ( 50 L) of sample was added onto a holey 
carbon-formvar coated copper TEM grid (100 mesh). 
Counting the number of VNBs generated per laser pulse  
The number of VNBs generated per laser pulse was determined by dark-field microscopy as we 
described before.65 Dispersions of  HA-AuNPs in water (1010 NPs/mL) were applied in a 50 
mm glass bottom dish (MatTek Corporation, US). After an equilibration of 1 hour, a single 7 
ns laser pulse was applied and the number of VNBs were counted in the irradiated area (~150 
µm laser beam diameter) of the dark field images. Dark field images were recorded with an 
illumination time of 10 ms after firing the laser pulse so as to capture the short-lived VNBs.  As 
the laser fluence (i.e. the energy density calculated as the energy of a single laser pulse divided 
by the laser beam area), increases, more AuNPs in the irradiated zone will form VNBs. Graphs, 
which show the number of VNBs as function of the laser fluence, were plotted.  
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 Cell culture and toxicity studies  
Human Müller cells (MIO-M1) (ATCC®) were cultured in high glucose Dulbecco's modified 
Eagle's medium GlutaMAX™, supplemented with 10% fetal bovine serum, 2 mM L-Glutamine 
and 100 U/mL penicillin-streptomycin (InVitrogen). Cells were regularly tested for 
Mycoplasma with the Mycoalert™ detection kit (Lonza, Rockland, ME) according to the 
manufacturer's instruction. Cells were grown in 96-well plate for 24h (7000 cells/well) at 37°C 
and under 5% CO2 to 80-90% confluence. Cells were passaged using DPBS (Gibco-
Invitrogen) and trypsin-EDTA (0.25%, Gibco-Invitrogen). 
To test the impact of the laser pulses on cell viability, the cells growing in wells were scanned 
through the laser beam (single scan; 200 µJ (~1.1 J/cm²) or 800 µJ (~ 4.5 J/cm²); 20 Hz 
frequency) using an electronic microscopy stage (HLD117, Prior Scientific, USA). The 
scanning speed was 2.1 mm/s and the distance between subsequent lines was 0.1 mm. With 
these parameters, one can assume that each cell was exposed to one single laser pulse.66 Cell 
viability was measured by MTT assay (Sigma-Aldrich) 24 hours after laser treatment. In each 
well, the cell medium was removed and replaced by the MTT reagent (100 µl, 1.5 mM) which 
was incubated with the cells for 3 hours at 37 °C. Afterwards, in each well, the reagent was 
replaced by DMSO to dissolve the formazan crystals, and the plate was placed on a shaker for 
1 hour. The readout was performed using a plate spectrophotometer (PerkinElmer VICTOR3 
1420 Multilabel Counter®) measuring the absorbance at 595 nm and 650 nm as a reference 
wavelength. 
To test the impact of the laser pulses in the presence of gold NPs on cell viability, cells were 
grown in a 96-well plate for 24 hours (7000 cells/well). The cell medium was then discarded 
and replaced by fresh cell medium containing 10 nm HA-AuNPs (1012 particles/ml) and 
collagen fibers (0.02 mg/ml). Cells were incubated for 4 hours. Subsequently, a microscope 
cover glass was placed on the top of the wells and stuck with nunc sealing tapes. This allowed 
to invert the cell plate without leakages. By inverting the cell plate (as illustrated in panel C of 
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Figure 10), the laser beam first hit the collagen fibers while the cell monolayer is located at  
approximately 10 mm (corresponding to the height of a well), a situation which corresponds to  
an opacity located at the center of the vitreous.16 Each well was then scanned through the laser 
beam as described above. Immediately after, cell viability was measured by MTT assay as 
described above. 
Statistical significance 
Student’s t-test (two-tailed) was used to calculate statistical significance. Differences were 
considered significant when p < 0.05. 
Supporting information 
Movie S1. Diffusion measurements (SRAF) on HA-AuNPs in water. 
Movie S2. Diffusion measurements (SRAF) on cat-AuNPs in bovine vitreous. 
Movie S3. Diffusion measurements (SRAF) on HA-AuNPs in bovine vitreous. 
Movie S4. HA-AuNP assisted photo-ablation of collagen fibers in bovine vitreous. 
Movie S5. HA-AuNP assisted photo-ablation of a human vitreous opacity. 
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